523 related articles for article (PubMed ID: 28232409)
1. Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.
Jo HE; Glaspole I; Grainge C; Goh N; Hopkins PM; Moodley Y; Reynolds PN; Chapman S; Walters EH; Zappala C; Allan H; Keir GJ; Hayen A; Cooper WA; Mahar AM; Ellis S; Macansh S; Corte TJ
Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28232409
[TBL] [Abstract][Full Text] [Related]
2. Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.
Jo HE; Glaspole I; Moodley Y; Chapman S; Ellis S; Goh N; Hopkins P; Keir G; Mahar A; Cooper W; Reynolds P; Haydn Walters E; Zappala C; Grainge C; Allan H; Macansh S; Corte TJ
BMC Pulm Med; 2018 Jan; 18(1):19. PubMed ID: 29370786
[TBL] [Abstract][Full Text] [Related]
3. Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry.
Gao J; Kalafatis D; Carlson L; Pesonen IHA; Li CX; Wheelock Å; Magnusson JM; Sköld CM
Respir Res; 2021 Feb; 22(1):40. PubMed ID: 33546682
[TBL] [Abstract][Full Text] [Related]
4. Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis.
Paterniti MO; Bi Y; Rekić D; Wang Y; Karimi-Shah BA; Chowdhury BA
Ann Am Thorac Soc; 2017 Sep; 14(9):1395-1402. PubMed ID: 28388260
[TBL] [Abstract][Full Text] [Related]
5. Multiple breath washout: A new and promising lung function test for patients with idiopathic pulmonary fibrosis.
Nyilas S; Schreder T; Singer F; Poellinger A; Geiser TK; Latzin P; Funke M
Respirology; 2018 Aug; 23(8):764-770. PubMed ID: 29573509
[TBL] [Abstract][Full Text] [Related]
6. Eligibility for anti-fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing.
Burgess A; Goon K; Brannan JD; Attia J; Palazzi K; Oldmeadow C; Corte TJ; Glaspole I; Goh N; Keir G; Allan H; Chapman S; Cooper W; Ellis S; Hopkins P; Moodley Y; Reynolds P; Zappala C; Macansh S; Grainge C
Respirology; 2019 Oct; 24(10):988-995. PubMed ID: 30924257
[TBL] [Abstract][Full Text] [Related]
7. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry.
Glaspole IN; Chapman SA; Cooper WA; Ellis SJ; Goh NS; Hopkins PM; Macansh S; Mahar A; Moodley YP; Paul E; Reynolds PN; Walters EH; Zappala CJ; Corte TJ
Respirology; 2017 Jul; 22(5):950-956. PubMed ID: 28166611
[TBL] [Abstract][Full Text] [Related]
9. Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry.
Snyder L; Neely ML; Hellkamp AS; O'Brien E; de Andrade J; Conoscenti CS; Leonard T; Bender S; Gulati M; Culver DA; Kaner RJ; Palmer S; Kim HJ;
Respir Res; 2019 May; 20(1):105. PubMed ID: 31142314
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry.
Wuyts WA; Dahlqvist C; Slabbynck H; Schlesser M; Gusbin N; Compere C; Maddens S; Lee YC; Kirchgaessler KU; Bartley K; Bondue B
Respir Res; 2019 Oct; 20(1):231. PubMed ID: 31651324
[TBL] [Abstract][Full Text] [Related]
11. The predictors of mortality in IPF - Does emphysema change the prognosis?
Tokgoz Akyıl F; Sevim T; Akman C; Aksoy E; Ağca M; Aktas O; Akyıl M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):267-274. PubMed ID: 27758993
[TBL] [Abstract][Full Text] [Related]
12. The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis.
Guenther A; Krauss E; Tello S; Wagner J; Paul B; Kuhn S; Maurer O; Heinemann S; Costabel U; Barbero MAN; Müller V; Bonniaud P; Vancheri C; Wells A; Vasakova M; Pesci A; Sofia M; Klepetko W; Seeger W; Drakopanagiotakis F; Crestani B
Respir Res; 2018 Jul; 19(1):141. PubMed ID: 30055613
[TBL] [Abstract][Full Text] [Related]
13. Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.
Serajeddini H; Rogliani P; Mura M
Lung; 2018 Dec; 196(6):707-713. PubMed ID: 30151723
[TBL] [Abstract][Full Text] [Related]
14. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis.
Zappala CJ; Latsi PI; Nicholson AG; Colby TV; Cramer D; Renzoni EA; Hansell DM; du Bois RM; Wells AU
Eur Respir J; 2010 Apr; 35(4):830-6. PubMed ID: 19840957
[TBL] [Abstract][Full Text] [Related]
15. Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures.
Jacob J; Bartholmai BJ; Rajagopalan S; Kokosi M; Nair A; Karwoski R; Walsh SL; Wells AU; Hansell DM
Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 27811068
[TBL] [Abstract][Full Text] [Related]
16. Independent Clinical Factors Relevant to Prognosis of Patients with Idiopathic Pulmonary Fibrosis.
Song H; Sun D; Ban C; Liu Y; Zhu M; Ye Q; Yan W; Ren Y; Dai H
Med Sci Monit; 2019 Jun; 25():4193-4201. PubMed ID: 31166938
[TBL] [Abstract][Full Text] [Related]
17. Validation of the prognostic value of MMP-7 in idiopathic pulmonary fibrosis.
Tzouvelekis A; Herazo-Maya JD; Slade M; Chu JH; Deiuliis G; Ryu C; Li Q; Sakamoto K; Ibarra G; Pan H; Gulati M; Antin-Ozerkis D; Herzog EL; Kaminski N
Respirology; 2017 Apr; 22(3):486-493. PubMed ID: 27761978
[TBL] [Abstract][Full Text] [Related]
18. Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis.
Costabel U; Albera C; Bradford WZ; Hormel P; King TE; Noble PW; Sahn SA; Valeyre D; du Bois RM
Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):198-205. PubMed ID: 25363219
[TBL] [Abstract][Full Text] [Related]
19. Gender differences at presentation of idiopathic pulmonary fibrosis in Sweden.
Kalafatis D; Gao J; Pesonen I; Carlson L; Sköld CM; Ferrara G
BMC Pulm Med; 2019 Nov; 19(1):222. PubMed ID: 31771560
[TBL] [Abstract][Full Text] [Related]
20. Assessing the Therapeutic Response to Pirfenidone in Idiopathic Pulmonary Fibrosis: Can We Do Better than with Forced Vital Capacity Alone?
Hosein K; Le J; Mura M
Lung; 2017 Feb; 195(1):101-105. PubMed ID: 27858160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
